REGENXBIO Inc. (RGNX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$170.4M

Net Income/Loss (FY2025)

-$193.9M

Total Assets (FY2025)

$453.0M

Total Equity (FY2025)

$102.7M

Cash Flows from Operating Activities (FY2025)

-$124.0M

Source: REGENXBIO Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.